Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production

Modified Vaccinia Ankara (MVA) virus is a promising vector for vaccination against various challenging pathogens or the treatment of some types of cancers, requiring a high amount of virions per dose for vaccination and gene therapy. Upstream process intensification combining perfusion technologies,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biotechnol J
Autors principals: Gränicher, Gwendal, Tapia, Felipe, Behrendt, Ilona, Jordan, Ingo, Genzel, Yvonne, Reichl, Udo
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7435511/
https://ncbi.nlm.nih.gov/pubmed/32762152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/biot.202000024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars